1Vintzileos AM, Guzman ER, Smulian JC, et al. Indication-specific accuracy of second-trimester genetic ultrasonography for the detection of trisomy 21. Am J Obstet Gynecol, 1999,181:1045-1048.
2Bromley B, Shipp T, Benacerraf BR, et al. Genetic sonogram scoring index: accuracy and clinical utility. J Ultrasound Med, 1999,18:523-528.
3Vergani P, Locatelli A, Piccoli MG, et al. Best second trimester sonographic markers for the detecrion of trisomy 21. Am Ins Ultrasound Med,1999,18:469-473.
4Verdin SM, Economides DL. The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry. Br J Obstet Gynecol, 1998,105:63-67.
5Snijders RJM, Noble P, Sebire N,et al. UK multicentre project in assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet, 1998,352: 343-346.
6Schuchter K, Wald N, Hackshaw AK,et al. The distribution of nuchal translucency at 10-13 weeks of pregnancy. Prenat Diag, 1998,18:281-286.
7Kubas C. Noninvasive means of identifying fetuses with possible Down syndrome: a review. J Perinat Neonatal Nurs, 1999,13:27-46.
8Locatelli A, Piccoli MG, Vergani P, et al. Critical appraisal of the use of nuchal fold thickness measurements for the prediction of Down syndrome. Am J Obstet Gynecol, 2000,182:192-197.
9Hafner E, Schuchter K, Liebhart E, et al. Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4233 unselected pregnant women. Prenat Diagn, 1998,18:29-34.
10Thilaganathan B, Olawaiye A, Sairam S, et al. Isolated fetal echogenic intracardiac foci or golf balls: is karyotyping for Down's syndrome indicated? Br J Obstet Gynecol, 1999,106:1294-1297.
